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Abstract
The  use  of  nanoparticles  has  increased  in  consumer  products  in  recent  decades;
however, concerns regarding their safety remain. Zinc oxide is used in sunblocking
and  may  generate  free  radicals  in  response  to  UV  illumination,  leading  to  DNA
damage and an immunological response. With high‐resolution, high‐contrast imaging
in biological tissue, multiphoton microscopy is able to separate nanoparticles signals
from endogenous  fluorophores.  It  has  been  proven  to  be  very  useful  in  imaging
penetration  of  zinc  oxide  nanoparticles  in  skin  and  in  combination  with  fluores‐
cence lifetime imaging microscopy study cellular function as well. This chapter aims
to review the use of these imaging techniques in studying the uptake and distribu‐
tion  of  nanoparticles  in  skin  and  liver.  Due  to  the  questionable  clinical  use  and
possible  toxicity  of  nanoparticles,  it  is  important  to  study their  pharmacokinetics.
Some nanomaterials  have been identified as relatively toxic  to humans and a few
metal  nanoparticles  have  been  reported  to  penetrate  and  be  detected  in  blood.
Multiphoton microscopy has high resolution and is able to visualize nanoparticles,
due to their optical properties, in vivo. The addition of fluorescence lifetime imaging
makes it possible to measure the physiochemical environment, with outputs that can
be statistically  analyzed,  posing an advantage over  fluorescence intensity  imaging
only.
Keywords: multiphoton microscopy, fluorescence lifetime imaging microscopy, nano‐
particles, skin, liver
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1. Introduction
Nanoparticles (NPs) are particles ranging from 1 to 100 nm in size and are a promising
pharmaceutical tool for drug delivery and functionalized cosmetic products like sunscreens.
There are growing public and regulatory concerns of topical application of NPs, due to the
increasing manufacturing of NPs in commercial products as well as continuing discovery of
new applications. NPs are available in several different shapes, such as sphere, rod, cylinder,
and cube. Furthermore, they can be soft or hard, aggregated or dispersed. NPs present in
commercial products are often made from metals such as gold and silver or metal oxides like
zinc oxide and titanium oxide, but also include quantum dots (QDs),  carbon nanotubes,
fullerenes, and lipid‐based materials. From an environmental and occupational health and safety
point of view, it is important to investigate NPs interaction with organs following unintended
exposure. On the other hand, it is very necessary to study their properties in active drug delivery
and clearance without adverse effects for therapeutic and cosmetic applications. Properties,
such as particle size and shape, surface charge, pH, formulation, are important factors in
determining the penetration of NPs in the skin. Toxicity of NPs is mainly of concern for the
smaller particles. The skin may be more susceptible to NPs penetration if it is diseased, hot,
damaged, inflamed, hydrated, dry, or moisturized. Positively charged NPs are most prefer‐
red for skin penetration [1].
Determining the presence or absence as well as concentration of NPs in biological tissue has
been enabled by multiphoton microscopy (MPM), especially in investigating interactions of
NPs with human skin [2].
Most knowledge in the biological world has been gathered from studying images [3]. Thus, a
growing interest for live‐tissue imaging has evolved. In conventional confocal microscopy, the
intensity from the beam is approximately uniform above and below the focal plane, which
results in the specimen generating fluorescence out of the focal plane that is rejected by the
pinhole. This leads to the specimen being subjected to photobleaching and photodamage,
affecting image quality, and tissue health [4]. MPM avoids this because a much smaller area
of the specimen is being stimulated by the excitation light source and no out of focus light is
generated, which leads to photobleaching being restricted to the focal point only [4, 5]. At an
excitation wavelength in the near infrared range (NIR, ∼ 700–1000 nm), the photon penetra‐
tion depth of the incident light is maximized, and the tissue scattering and absorption are
minimized [6, 7].
In confocal microscopy (single photon), fluorescence occurs when a photon is absorbed by a
fluorescent molecule and raises an electron to an excited energy state (Figure 1). When the
electron returns to the ground state, it converts the absorbed energy to heat, by transferring
the energy to another molecule emitting a lower energy photon [8, 9], producing an image. In
MPM, two (or more) photons of the same energy from a pulsed laser (usually femtosecond
laser) interact with a molecule to produce excitation equivalent to the absorption of a single
photon possessing twice (or multiple) the energy (Figure 1). If the excited molecule is
fluorescent, it can emit a single photon [8–10].
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Figure 1. Jablonski energy diagram (adapted from Refs. [8–11]). Imagine a fluorescent molecule with single absorption
and emission at 450 and 500 nm, respectively. In order to excite electron(s) from this molecule, light from a laser is
needed. The electron(s) is then raised into a higher excited state, where it decays rapidly into the ground vibrational
state within the electronically excited state. From there the electron can return to the electronically ground state by
emitting light, which can yield in fluorescence. The emitted light has lower energy (higher wavelength) than the absor‐
bed light. The emission spectrum of fluorescence excited by MPM is usually similar to the one excited with single
photon excitation. To excite the molecule with two‐photon, two photons of equal wavelengths, which together meet
the energy gap between the ground and excited states, are needed (here 900 nm).
An important application of MPM is to image the physiology, morphology, and cell‐cell
interactions in intact tissue of live animals with high resolution. However, one limitation is
that it cannot quantitatively study cellular function on a molecular level [12]. MPM in
combination with fluorescence lifetime imaging microscopy (FLIM), however, can identify
fluorophores with overlapping spectral properties. Furthermore, it enables insights into their
biological function by being sensitive to the binding site and the environmental surrounding
[13]. The fluorescence lifetime is proportional to the reciprocal Einstein coefficient of the
spontaneous emission, that is, to the sum of the rate constants of all possible return paths for
the electron from the excited state to the ground state that is not stimulated emission [14]. This
is determined by both intramolecular and intermolecular events [4]. FLIM has been descri‐
bed as a direct approach to monitor energy transfers between fluorophore and the environ‐
ment, for example, DNA binding, which change the fluorescence lifetime of that
fluorophore [15]. FLIM is particularly important when identifying fluorophores with over‐
lapping spectral properties [13]. One application for FLIM in liver imaging is to study levels
of the autofluorescent NADH, as a direct measure for the redox state as a metabolic marker of
the cells [8].
The principle of FLIM is illustrated in Figure 2. Imagine a sample with two regions, each with
equal intensity, but two different fluorescence lifetimes, one shorter (τ1) and one longer (τ2).
τ2 could be due to binding to other molecules, change in pH, cation concentration, oxygen
concentration, or polarity. The intensity image itself can not reveal these environmental
differences (Figure 2a), but the FLIM image can (Figure 2b and c). The fluorescence lifetimes
within a FLIM image can be presented on a grey (Figure 2b) or colour scale (Figure 2c) or as
Multiphoton and Fluorescence Lifetime Imaging Microscopy in Studying Nanoparticle Pharmacokinetics in Skin and
Liver
http://dx.doi.org/10.5772/63452
109
three‐dimensional (3D) surface where the height represents the local decay times (Figure 2d)
[16].
Figure 2. Principles of fluorescence lifetime imaging (FLIM). (a) Intensity (I) cannot reveal any difference in the sur‐
rounding environment; (b) FLIM enables distinguishing the two components with different fluorescence lifetime and
can give insights into biological function (grey scale represents fluorescence lifetimes, where τ2 > τ1). (c) Fluorescence
lifetimes can also be colour coded or; (d) displayed as third coordinate, resulting in a 3D image (adapted from Ref.
[Lakowitz et al., Fluorescence lifetime imaging of free and protein-bound NADH. Proceedings of the National Academy of
Sciences 1992 89(4): 1271-1275).
MPM can be used to image fluorescent and sometimes even nonfluorescent NPs in living cells,
tissue, and organs in vivo. Nonfluorescent NPs can have nonlinear optical properties so that
they can become visible for MPM (e.g., zinc oxide (ZnO) NPs, gold (Au) NPs, and silver (Ag)
NPs) [17]. One physical phenomenon is second harmonic generation (SHG). It is based on
elastic scattering. The wavelength of the SHG signal is at the double frequency of the inci‐
dent excitation light of the femtosecond laser. The optical response is quasi‐instantaneous and
therefore can easily be identified by FLIM. A second process is the so‐called localized surface
plasmon resonance (LSPR) [18]. The LSPR signal can be tailored by modifying the size or the
shape of the NPs. This signal can be very broadband (inelastic phenomenon) and strong but
is also characterized by a very rapid optical response in the femtosecond range so that it also
can easily be identified by FLIM technique [19].
MPM has proven to be very useful in imaging the uptake of metal NPs, such as ZnO‐NPs, Au‐
NPs and Ag‐NPs in the skin. Additionally, NAD(P)H (NADH+NADPH) can be imaged
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simultaneously without the need for additional dyes using FLIM. This can help to under‐
stand how NPs affect the viable skin condition. The additional time‐resolved measurements
with FLIM can be used to differentiate NP signals from endogenous tissue [2]. This chapter
aims to critically review the use of these imaging techniques in studying the penetration of
NPs and quantum dots (QDs) into skin, how to facilitate intentional uptake, as well as the
uptake and distribution in the liver.
2. Topical application of zinc oxide nanoparticles
Zinc oxide NPs (ZnO NPs) are incorporated into a plethora of commercially available
formulations including sunscreens, cosmetics such as mineral‐based make‐up, and nappy rash
ointments. Though ZnO NPs are considered to be safe after topical application [20], there have
been concerns raised about the lack of assessment of toxicity under “in‐use” conditions [21].
ZnO NPs are transparent and affords the viable epidermis broad spectrum protection from
harmful UV radiation. Irradiation of ZnO NPs, however, can result in the production of
reactive oxygen species (ROS) that are harmful if exposed to the keratinocytes within the viable
epidermis [22]. It is therefore of importance to delineate the deposition of ZnO NPs after topical
application to comprehensively assessing whether ZnO NPs can penetrate the stratum
corneum and reach the viable epidermis. A ZnO NP suspension was applied to human skin
in vivo at 10% wt for 6 hours and then occluded to simulate clothing covering the skin with the
applied sunscreen. It was found that occlusion, and thus, skin hydration does not aid the
penetration of ZnO NPs into human skin and no localized toxicity was observed within the
viable epidermis using metabolic lifetime imaging [23]. In this study, the photoluminescence
of ZnO NPs was spectrally resolved from that of the endogenous fluorophores, and thus, the
deposition was mapped after application to the volunteers’ forearms. The fluorescence lifetime
amplitude, α1%, of ZnO NPs (multiphoton‐excited photoluminescence) was found to be
distinct from that of the autofluorescence. This enabled the authors’ to map the distribution of
ZnO NPs after application to viable skin in vivo. Further, using MPM–FLIM, the free‐to‐bound
ratio of endogenous NAD(P)H was determined to elucidate any effect ZnO NP application
had on the redox state of the viable epidermis.
Other studies conducted include the in vivo application of ZnO NPs with massage and arm
flexing in which the conclusions were that again no ZnO NP penetration as observed with the
exception of ZnO NPs within the sebaceous gland of one volunteer and no localized toxicity
was observed by metabolic imaging [23]. An in vivo study was also conducted to assess any
ZnO penetration after repeated exposure [25] as the cancer council advises the public to
reapply sunscreen every 2 hours [24]. In this study, once again no ZnO NP penetration or
localized toxicity within the viable epidermis was observed even after repeated liberal
application to volunteers’ forearm [25]. Lin et al. applied ZnO NPs to intact human skin and
also skin that was tape‐stripped (20×), or had psoriatic and atopic dermatitis lesions. The study
showed that the ZnO NP photoluminescence signal was most intense at the skin surface after
application to impaired lesioned skin compared to intact skin in vivo. In this study, no
penetration of ZnO NP was observed within the viable epidermis after application of ZnO NPs
in caprylic capric triglyceride (CCT) [26].
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As NPs have a high surface‐to‐volume ratio, the reactivity and dissolution of constituent ions
increases with decreasing diameter of the NP. Zinc ion release and percutaneous absorption
has been observed after topical ZnO NP application to human skin both in vivo [27–29] and in
vitro [30]. Further, NPs are known to accumulate within the hair follicles and undulations of
human skin for up to 10 days [31] whereby they may act as a reservoir undergoing dissolu‐
tion into constituent solubilized species within these reduced environments. To increase
stability, reduce dissolution and production of ROS, coated ZnO NPs have been employed
within formulations. Leite‐Silva et al. [23] investigated the deposition of ZnO NPs after
application to in vivo human skin within various formulations. MPM–FLIM was used once
again to simultaneously map ZnO NP deposition whilst also determining the NAD(P)H free‐
to‐bound ratio of the underlying viable epidermis after application of both coated and
uncoated ZnO NPs in (a) CCT suspension, (b) a gel formulation, (c) oil‐in‐water emulsion,
and (d) water‐in‐oil emulsion. The study reported the deposition of the ZnO NPs only within
the superficial layers of the stratum corneum and within the furrows as reported previously
after application in a water‐in‐oil emulsion (Roberts MS, Roberts MJ, Robertson TA, Sanchez
W, Thorling CA, Zou Y, Zhao X, Becker W and Zvyagin AV. In vitro and in vivo imaging of
xenobiotic transport in human skin and in the rat liver. Journal of Biophotonics 1(6): 478-493,
2008). The exception was minimal ZnO NP penetration was observed within isolated areas in
parallel to the furrow within the stratum granulosum after application of coated ZnO NPs in
a water‐in‐oil emulsion observed in Figure 3 [23]. This, however, did not result in a change in
redox state within the stratum granulosum; therefore, the penetrated ZnO NPs did not cause
toxicity [23].
Figure 3. Pseudocoloured MPM–FLIM images of human skin treated with ZnO NPs in vivo. ZnO NPs were dispersed
in three types of formulations, gel, emulsion E1 o/w, and emulsion E2 w/o in coated or uncoated form. Control images
do not contain any NPs. The green colour corresponds to skin autofluorescence (α1% 45‐85), whereas the orange‐red
colour corresponds to ZnO‐NPs photoluminescence (α1% 90–100). Scale bar is 20 μm. The colour scale bar represents
α1% 0–100.
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3. Topical application of gold nanoparticles
Gold NPs (Au NPs) are being increasingly investigated for topical drug delivery due to their
monodispersed controllable size, the ability to functionalize the surface of the Au NPs and due
to their low reactivity potential. Recently, Au NPs have been investigated as a drug delivery
platform in the treatment of psoriasis [32] and as contrast agents in skin cancer imaging [33].
The Au NP (6–15 nm in diameter) penetration study showed 15 nm AuNP in aqueous solution
was also observed by MPM–FLIM to aggregate within furrows of skin after treated on excised
viable skin sample and also showed penetration of 6 nm Au NP suspended in toluene within
the stratum spinosum of the viable epidermis [34]. No change in the redox state of the viable
epidermis was observed when Au NPs were applied to the skin in an aqueous vehicle though
a change in redox state was observed when Au NPs were applied in toluene [34]. The authors’
further investigated the penetration of Au NPs into skin using dimethyl sulfoxide (DMSO), a
known chemical penetration enhancer, and found that DMSO enhanced the penetration of Au
NPs into skin [35]. A study also showed that Au NP skin penetration was found to be size
dependent with 6 nm Au NPs penetrating to higher degree than 15 nm Au NPs [35]. Fernandes
et al. found that the skin penetration on Au NPs could be tailored depending on the surface
chemistry and shape of the NP [36]. Larese Filon et al. also concluded that Au NPs can penetrate
into both intact and impaired human skin in vitro [37]. Conversely, Lin et al. found no
penetration of Au NPs after topical application to human skin in vivo (as shown in Figure 4).
In this study, Au NPs of increasing diameter 10, 30, and 60 nm were applied to viable ex vivo
human skin and MPM–FLIM was used to assess any percutaneous absorption of Au NPs. No
penetration of Au NPs was observed past the stratum corneum and no change in the redox
state of the viable epidermis was observed indicating no localized toxicity [38]. The scientific
community has yet to reach a consensus on whether inorganic NPs can penetrate human skin
as exhibited by conflicting results within the literature.
4. Topical application of other nanoparticles
SECosomes are flexible nanovesicles constituted from surfactant, ethanol, and cholesterol,
hence the name SECosomes. MPM–FLIM was used to observe the penetration of SECosomes
into viable ex vivo human skin as deep at 40 μm within the viable epidermis, which resulted
in a shift of lifetime for NAD(P)H [39]. Silver NPs (Ag NPs) are found within a wide variety
of personal care products including deodorants’, antibacterial under garments, and wound
dressings. To determine whether Ag NPs penetrate human skin in vivo, Ag NPs were applied
to intact or tape stripped skin. No statistically significant difference in metabolic rate
measuring the inverse ratio of free‐to‐bound NAD(P)H (α1/α2) was observed within the viable
epidermis [40]. In a more recent study, the shape dependence of Ag NPs and their penetration
into human skin was determined on ex vivo human skin [19]. No Ag NPs either cube, sphere,
or truncated plates were observed within the viable epidermis in intact skin but Ag NP plates
were found within the wound bed of burned human skin. In this study, Ag NPs penetration
into both intact and burned human skin was assessed through detection of both the second
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harmonic generation (SHG) signal and the localized surface plasmon resonance (LSPR) of the
NPs. Using MPM–FLIM, the detected nonlinear optical characteristics (SHG and LSPR) found
that the Ag NPs accumulated within the furrows of the skin, and in particular, the truncated
Ag NP plates showed great substantivity within the superficial layers of the stratum corneum
but that no penetration into the viable epidermis was observed for intact skin [19]. The authors’
also observed that Ag NP spheres accumulated within and around the hair follicle shafts after
topical application. This was also supported by the work of Zhu et al. [41] as they too did not
observe any penetration of Ag NPs into the viable epidermis of intact porcine skin but did
image Ag NPs within the hair follicles using MPM–FLIM and Raman scattering microscopy.
QDs are 2–10 nm fluorescent semiconductor nanomaterials with a larger excitor Bohr radius
than the NP radius, making these nanomaterials to undergo quantum confinement. As a result,
QDs have characteristic excitation states and larger bandgap values than bulk materials.
Emission wavelengths is dependent on size, bandgap increases as the radius decreases (i.e.,
for smaller QDs). They have greater resistance to photobleaching and have higher quantum
Figure 4. En face MPM–FLIM images of treated human viable skin. FLIM images showing the different layers of ex‐
cised full‐thickness skin (stratum corneum, granulosum, spinosum, and basale) after 24‐hour treatment with Au NPs
suspended in sodium citrate. Images are pseudocoloured based on α1% signal (skin autofluorescence 0–95% and
AuNPs 95–100% signal). No Au NP signal was detected in the saline control (a)–(d) and detected in the sodium citrate
control (e)–(h). The AuNP‐treated groups, 10 nm (i)–(l), 30 nm (m)–(p), and 60nm (q)–(t), resulted in signal throughout
the stratum corneum. Scale bar indicates 20 μm. Colour bar, blue to red indicates α1% 0–100%.
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yield than conventional fluorophores [42]. Here, they characterized water‐soluble cadmium
selenide–zinc sulphide quantum dots for MPM imaging in live animals. They visualized QDs
dynamically through mice skin in capillaries hundreds of micrometres deep [43].
The advantages that MPM‐FLIM provides over other imaging techniques as outlined in the
Introduction section have enabled numerous researchers to map the deposition and poten‐
tial percutaneous absorption of a wide variety of NPs into skin. Further elucidation is required,
however, to determine whether NPs can penetrate human skin due to conflicting conclu‐
sions within the literature and with the nanotechnology sector rapidly increasing the risk of
dermal exposure to NPs will increase.
4.1. How do we improve penetration of nanoparticles for drug delivery?
The penetration of NPs can be improved by penetration enhancers, such as oleic acid, urea,
sodium lauryl sulphate, polysorbate, and DMSO. MPM was used to visualize the penetra‐
tion of a fluorescent NP with the assistance of oleic acid. The results showed that oleic acid
was effective in facilitating transdermal delivery of NPs [44]. Au NPs penetration was studied
with the chemical enhancers, urea, sodium lauryl sulphate, polysorbate, and DMSO, and it
was evident that the penetration was induced by DMSO [35]. Similarly, chemical enhancers
can increase penetration of ZnO NPs, by increasing lipid fluidity or by extracting noncova‐
lently bound amphiphilic lipid in the stratum corneum [26].
Another way of increasing penetration of NPs is by using microneedles, which can create pores
in the stratum corneum layer, which enables delivery of NPs to the deeper layers of the skin.
Gantrez R_AN‐139 microneedle successfully did this [45]. Two‐photon polymerization of an
acrylate‐based polymer was used to fabricate microneedle devices for transdermal drug
delivery and MPM visualized QDs penetration in porcine skin by a microneedle device [42].
5. Nanoparticles disposition in the liver
NPs are increasingly being used for the detection and treatment of human diseases, in
applications such as drug and gene delivery, imaging, and diagnostics [46, 47]. However their
short in vivo half‐lives limit their clinical utility and can lead to hepatotoxicity [46]. It is
important to monitor the biodistribution of NPs after intravenous administration in order to
evaluate their efficacy and possible side effects. The physiochemical properties of NPs, such
as size, shape, surface charge are important in determining the biodistribution [2–5]. For
example, hydrophobic NPs are rapidly removed by reticuloendothelial system (RES), mainly
by the liver and spleen [46]. Additionally, intravital imaging showed that positively charged
NPs where taken up by the hepatocytes (liver cells), whereas negatively charged NPs were
found to be taken up by Kupffer cells, liver macrophages, instead [46]. The positively charged
NPs have the potential to be cleared via hepatobiliary excretion; however, the negatively
charged NPs portends significant hepatotoxicity due to their accumulation in Kupffer cells
[46]. If NPs are taken up by hepatocytes, this would be through receptor‐mediated endocy‐
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totic processes [48]. This is in contrast to smaller molecules, such as RH123 and fluorescein,
which are taken up by diffusion and transporter proteins in the liver membranes [49].
In a recent study, a multimodal nonlinear label‐free imaging technique to pinpoint polymer‐
ic NPs within the intestine and liver was done. Encapsulation of active substances within
nanoscale particles can enhance bioavailability and biocompatibility, resulting in targeted
drug delivery, solubility, and bioactivity and reducing toxicity. They used MPM to show
cellular structures, SHG to visualize collagen and CARS to generate chemical‐specific images
of polymer‐based NPs with contrast derived from the molecular vibration of carbon–deuteri‐
um bonds within the polymer's palmitic acid chains. These modalities combined give accurate
location of the NPs in relation to the cellular structure in the liver, gall bladder, and intestine
[50].
The use of MPM to visualize the delivery of Cy5‐siRNA with lipid NPs vehicles to hepato‐
cytes was shown by Chen et al. They analysed the diffusion of Cy5‐siRNA into the hepato‐
cytes by computation of the percentage signal strength in the region of interest over time [51].
Quantum dots (QDs) are nanomaterials recognized as promising diagnostic and imaging
agents. QDs are the most effective semiconductor materials for applications in the field of
bioimaging, since they have unique optical and photophysical properties, with high quan‐
tum yield and strong fluorescence at both visible and NIR wavelengths. QDs are also stable
and retain their fluorescence for a long period of time. QDs have been found to be retained in
the organs of the RES for over 22 days after injection, suggesting that they are consumed by
mononuclear phagocytes [52]. QDs are particularly well suited for the detection of low
abundance antigens, such as hepatitis C virus (HCV), because they are less prone to photo‐
bleaching. MPM has been used in combination with QDs to visualize the distribution of HCV‐
infected cells within the liver [53].
In a previous study, our group applied MPM–FLIM to investigate the in vivo subcellular,
spatiotemporal disposition of negatively charged QDs in rat liver. The cellular behaviour of
QDs was found to be very different from traditional fluorescent molecules, rhodamine 123
(RH123) and fluorescein (Figure 5). Results showed that QDs were quickly detected in the liver
sinusoids immediately after injection and were not taken up by hepatocytes, but the fluores‐
cence stayed in the sinusoids and started to decrease after about 60 min. The QDs were found
to be taken up by Kupffer cells and liver sinusoidal endothelial cells (LSECs).
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Figure 5. False‐coloured images of QDs, RH123, and fluorescein distribution in the rat liver at 5 min after injection
(adapted from Ref. [49]) using high (×40) and low (×10) magnification objectives. Red colour represents autofluores‐
cence of the liver excited at 740 nm. Green colour represents the fluorophores, QDs, RH123, and fluorescein, excited at
900 and 920 nm. Scale bar is 20 μm, H = hepatocyte, S = sinusoid, arrow points to bile ducts.
The distribution of these QDs was similar to the distribution of rhodamine B isothiocyanate/
dextran 7000, which is a fluorescent marker for labelling the sinusoids of the liver. Addition‐
ally, this is in accordance to another study where they found no uptake of negatively charg‐
ed fluorescein isothiocyanate‐labelled mesoporous silica NPs [16]. Both RH123 and fluorescein
are excreted through the bile, and hence, the fluorescence signal in the liver declined rapidly,
but since these QDs were not excreted through the bile, the fluorescence declined much slower.
The fluorescence lifetime of the sinusoids increased after QDs injection, which was due to the
long lifetime of QD [49].
Fast and reliable ratiometric FLIM (rmFLIM) approach is described to analyse the distribu‐
tion of protein‐ligand complexes in the cellular context. In combination with Forster reso‐
nance energy transfer (FRET), FLIM can be used to map protein–protein interactions on the
nanometer‐scale in living cells. Organic fluorophores label the ligands in the case of mem‐
brane receptors or intracellular proteins that bind extracellular ligands. Imaging based on
fluorescence intensity is often used to localize cellular sites where the ligand binds to its
cognate receptor, but these techniques may be biased by unspecific binding and distribution
of the ligand in various subcellular compartments. FLIM is sensitive to the physiochemical
environment, posing an advantage over fluorescence intensity measurements. In this study,
they show a fast and reliable FLIM‐based method for the localization of target molecules and
their discrimination against the fluorescent background of cell membranes and tissue. FRET
relies on the shortening of the donor lifetime due to the less energy transfer of radiation to the
acceptor. Physiochemical environment can also affect the fluorescence lifetime, for example,
quenching. The shortening of fluorescein's fluorescence lifetime when it binds to Cys316 in the
opsin molecule results from additional dynamic interaction of the bound dye with the
surrounding protein matrix, which functions as a quencher. A ratiometric FLIM (rmFLIM)
relies on the specific multiexponential lifetime signature of a protein–ligand complex that is
unique compared to the fluorescence lifetime distribution of the background. Only one
fluorophore is needed. rmFLIM was used to analyse the fate of a polymer‐based nanocarrier
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for drug delivery in the metabolic clearance process. They used a polyanionic, dendritic
polyglycerolsulfate (dPGS) labelled with a fluorescent indocarbocyanine dye (ICC, spectral‐
ly analogue to Cy3). In solution, this nanocarrier had 2 fluorescence lifetimes of 0.27 and 1.1
ns. Paraffin‐embedded liver section from rats, previously injected with dPGS‐ICC, was used
for FLIM measurements [54].
6. Conclusions and future directions
In this chapter, we review the use of MPM and FLIM to visualize the disposition of NPs and
QDs in the skin and liver. Nanotechnology and its applications in dermatology and drug
delivery have received a growing interest over the past years. Increased applications of NPs
have led to an enhanced unintentional skin exposure of NPs and it is therefore important to
study when and how NPs penetrate skin. Some conclusions of NP penetrations into skin are
as follows: (1) The SC forms an effective barrier to NPs penetration, but smaller‐sized NPs are
more likely to penetrate. (2) Hair follicles are an important collection site for NPs, and
increasingly so when the skin is massaged or flexed. (3) The surface charge and formulation
of NPs can affect its penetration.
Negatively charged QDs were found to distribute immediately after injection in the sinus‐
oids of mice livers and accumulated in Kupffer cells and LSECs. Positively charged NPs,
however, can be taken up by hepatocytes and subsequently be subjected to biliary excretion.
It is important to know where NPs are localized after intravenous injection as these cells are
emerging as significant targets for therapies in many liver diseases.
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